Concepedia
Statistics
Publications
14
Citations
658
H-Index
Active since
1987
Affiliations
Duke Medical Center(Current)
Duke University Hospital
Duke University
University of Chicago
Institute of Cytochemistry and Molecular Pharmacology
Stewart P. Johnson is an author at Duke Medical Center specializing in oncology, medicine, and chemotherapy.
Publications per year
1987–2010
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
Chau-Ming Cheng, Stewart P. Johnson, Stephen T. Keir et al. · Molecular Cancer Therapeutics · 2005 · 172 citations
Medicine, Cancer Biology, Oncology +15
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma
Jill Maxwell, Stewart P. Johnson, Jennifer A. Quinn et al. · Molecular Cancer Therapeutics · 2006 · 86 citations
Medicine, Molecular Biology, Oncology +17
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
Jill Maxwell, Stewart P. Johnson, Roger E. McLendon et al. · Clinical Cancer Research · 2008 · 83 citations · Full text
Modulation of cyclophosphamide activity by O ? 6 -alkylguanine-DNA alkyltransferase
Stewart P. Johnson, Natalia A. Loktionova, M. Eileen Dolan et al. · Cancer Chemotherapy and Pharmacology · 1999 · 55 citations
Medicine, Molecular Biology, Pharmacology +12
A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells
Meryem Bektas, Stewart P. Johnson, William E. Poe et al. · Cancer Chemotherapy and Pharmacology · 2009 · 41 citations
Medicine, Oncology, Pharmacology +14
1–5 of 14